Skip to content

Newsroom

type
year
Illustration image.png

102,428 Orion Corporation A shares converted into B shares

12/10/2021 Stock exchange release
Illustration image.png

ARASENS trial with darolutamide in combination with docetaxel and androgen deprivation therapy meets primary endpoint of significantly increasing overall survival in patients with metastatic hormone-sensitive prostate cancer

12/3/2021 Stock exchange release
Turvallisuuden_varmistajat.jpg

Ensuring the efficacy and safety of medicines

12/2/2021 Science and Partnering
Illustration image.png

Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2022 Annual General Meeting

11/25/2021 Stock exchange release
Illustration image.png

Orion Research Foundation grants 991,910 euros for research in 2022

11/11/2021 Press release
Illustration image.png

Orion Group Interim Report 1–9/2021

10/20/2021 Stock exchange release
Illustration image.png

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

10/8/2021 Stock exchange release
Illustration image.png

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

10/8/2021 Flagging notifications
Illustration image.png

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

10/8/2021 Stock exchange release
Illustration image.png

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

10/8/2021 Flagging notifications
Illustration image.png

Orion publishes Interim Report for January–September 2021 on Wednesday 20 October 2021

10/5/2021 Press release
Illustration image.png

Successor plan of the President and CEO of Orion

9/17/2021 Stock exchange release
Illustration image.png

90,889 Orion Corporation A shares converted into B shares

9/14/2021 Stock exchange release
Illustration image.png

Orion Corporation: Managers’ transactions – Kari Jussi Aho

8/25/2021 Managers transactions
Illustration image.png

Orion Corporation and Alligator Bioscience announce immuno-oncology research collaboration and license agreement

8/18/2021 Press release
Illustration image.png

Orion will remain as the owner of pharmaceutical manufacturing plant in Kuopio, Finland

8/17/2021 Press release
Illustration image.png

Orion Corporation signs European wide marketing and distribution agreement with Marinus Pharmaceuticals for ganaxolone

8/3/2021 Press release
Illustration image.png

CORRECTION: Orion Corporation: Managers’ transactions – Liisa Hurme

7/23/2021 Managers transactions